ASBA vs TECH · rev $1.10B vs P/E 65, rev $1.22B
Associated Banc-Corp 6.625% Fixed-Rate Reset Subordinated Notes due 2033 (ASBA) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Associated Banc-Corp 6.625% Fixed-Rate Reset Subordinated Notes due 2033 (ASBA) common stock listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported ASBA revenue for 2023-12-31 was $1.10B. Net income was $183.0M. Revenue was down 11.0% from 2022-12-31 to 2023-12-31. ASBA currently screens at market cap $0.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
ASBA currently screens at market cap $0. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the ASBA and TECH stock pages for the full models.
Not investment advice.